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Abstract 
Individuals in modern Western societies are experiencing increasing sedentary lifestyles, 
overindulgence of high fat, high-sugar diets, and extremely sterilized conditions, putting 
immense pressure on researchers and clinicians alike to come up with viable treatments for 
conditions implicated with an aging society. Emerging research have published the benefits of 
IMS and metabolic switching in a variety of neuroprotective, cellular stress resistance, and 
neuroplasticity pathways in animal models and clinical results from randomized trials of IMS 
regimens with susceptible human populations are soon to be published. The application of 
genome editing and next-generation sequencing (NGS) strategies to clinical and 
neurodegenerative research continues to elucidate the relationship between a patient’s specific 
genetic background and modern environmental stressors towards disease pathology. This study 
attempts to utilize novel CRISPR/Cas9 strategies to introduce targeted gene edits and explores the 
role of reduced ketone-body synthesis/metabolism with 3-hydroxymethyl-3-methylglutaryl-CoA 
lyase HMGCL KO, in the therapeutic and neuroprotective potential of intermittent metabolic 
switching in 3xTg mice, genetically predisposed for Alzheimer pathology. IMS-mediated 
attenuation of hippocampal spatial memory deficits was confirmed in 5-month-old 3xTg mice 
using Morris Water Maze and Aβ1-40, Aβ1-42, total tau and p-tau levels were calculated 
accordingly. Mice receiving time-restricted feeding (TRF) and caloric restriction (CR) regardless 
of KO performed better in the hippocampal-dependent spatial memory test and ELISA analysis of 
CSF revealed reduced p-tau levels of 3xTg WT TRF + CR mice relative to WT control or the two 
experimental groups. Overall, genetic modifications of key metabolic enzymes highlight the 
variable therapeutic results of the glucose to ketone metabolic switch on cognitive deficits 
depending on an organism’s genetic background.  
  
 4 
Emergence of Alzheimer Disease  
The NIH has stated that the percentage of the world population over 65 years old is expected to 
double to 1.6 billion people by the year 2050, putting immense pressure on researchers and 
society alike to provide reproducible solutions to the issues faced by an aging population and 
their families (Hebert et al., 2013). Accordingly, the rising prevalence of Alzheimer disease 
(AD) and other dementia-like disorders has placed genetic data analysis and transgenic animal 
studies at the forefront of pharmacogenetics and clinical research. Progress in understanding 
the complex etiology of early and late on-set forms of AD have largely stemmed from the 
application of molecular and cellular manipulations against genetic backgrounds implicated in 
disease progression and have shed light on the complex interaction of genetic and 
environmental factors in the pathogenesis of AD. This proposal attempts to address three main 
hypotheses: Can CRISPR/Cas9 transfected embryonic stem cells and surrogate transplantation 
lead to viable chimeric HMGCL KO strain in 3xTg AD mice? How does IMS affect cognitive 
abilities in 6-month-old 3xTg/HMGCL-/- compared to 3xTg/WT littermates? What effect does 
IMS and gene KO have on levels of Aβ protein and p-tau concentrations? Is cell death observed 
in hippocampal slices? 
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Alzheimer Disease Pathology 
Traditionally, Alzheimer disease pathology has been well characterized by the amyloid cascade 
hypothesis (Hardy & Higgins, 1992). This study concludes that the extracellular aggregation of 
amyloid beta (Aβ) protein from aberrant cleavage of the amyloid precursor protein (APP) leads 
to neurotoxic amyloid plaques, ultimately contributing to the formation of intracellular 
neurofibrillary tangles (NFTs), hyper-phosphorylated microtubule associated protein tau 
pathology, and subsequent cell death (Hardy & Higgins, 1992, Grundke-Iqbal et al., 1986). Since 
the early identification of mutations associated with APP, researchers have refined the diagnoses 
of familial early onset forms of AD to also include mutations in presenilin-1 or presenilin-2, which 
are the catalytic subunits of gamma-secretase, implicated in the pathway that generates the 
insoluble Aβ1-42 protein aggregates (Lanoiselée et al., 2017, Murphy & LeVine, 2010). 
Recently, Haass & Selkoe have demonstrated that small soluble oligomer intermediates formed 
in the aggregation process lead to synaptic dysfunction and that these insoluble Aβ1-42 plaques 
can act as “reservoirs of bioactive oligomers” in the etiology of AD (2007). Post-mortem analysis 
of AD patient brain tissue has confirmed both morphological hallmarks of the disease, the 
extracellular AB protein aggregates, and intracellular hyper-phosphorylated tau protein leading to 
cytotoxic insult and ultimately cell death, cognitive decline, and disease progression (Selkoe, 1991, 
LaFerna & Green, 2012, Thal & Brak, 2005). Mutations in this tau protein, responsible for 
microtubule assembly stability and microtubule binding, result in the protein’s hyper-
phosphorylation and propensity to form paired helical filaments causing subsequent axonal 
damage and neurofibrillary tangle formation (Matsue et al., 1994, Grundke-Iqbal et al., 1986). The 
mutations in the aforementioned genetic loci by themselves are not sufficient to cause cognitive 
decline associated with AD as studies have shown patients with elevated levels experience normal 
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physiologies. Therefore, disease progression is dependent on several other known risk factors 
including the apolipoprotein E allele (APOE-e4) in late-onset AD, inflammatory signatures, diet 
and exercise, and other environmental factors that affect neuron durability and synaptic coherence 
(Stritmatter et al., 1993, Wyss-Coray, 2006, Scarmeas et al., 2009, Butterfield et al., 2002, LaFerla 
& Green, 2012). Attention is given specifically to the complex gene-environment interaction of 
patients with familial forms of AD by inducing genetic knockouts to pre-existing model organisms 
through novel CRISPR/Cas9 systems and assessing relevant behavioral and morphological 
changes associated with the given modification. For this study, the triple transgenic mice (3xTg) 
contain three mutations associated with familial Alzheimer disease (APP Swedish, MAPT P301L, 
and PSEN1 M146V) and display progressive AB deposition as early as three to four months of 
age, extracellular deposition in the frontal cortex noticeable by six months becoming more 
extensive, and aggregates of altered hyper-phosphorylated tau are detected in the hippocampus 
(Oddo et al., 2003, Billings et al., 2005). Corresponding behavioral deficits in hippocampal spatial 
memory deficits and long-term potentiation have been determined in 3xTg mice and have 
continued to elucidate the age-dependent molecular and physiological manifestations of AD and 
other disease states (Billings et al., 2005, Clark et al., 2015, Sterniczuk et al., 2010, Orta-Salazar 
et al., 2013). 
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Gene Editing by CRISPR/Cas9 Systems 
Though the exact nature of the complex interaction of amyloid and tau pathologies in Alzheimer 
disease progression is still unresolved, researchers have benefitted greatly from the use of 
transgenic mice model organisms to imitate classical disease conditions and inducible genetic 
manipulations at sites relevant to human AD pathology through novel CRISPR-Cas9 systems. 
Recent literature has cited the development of sequence specific DNA nuclease technologies from 
microbial CRISPR (clustered regularly interspaced short palindromic repeat) systems and 
programmable Cas9 nucleases that have enhanced the efficiency and accuracy of targeted 
modifications to genomic sequences of living cells and model organisms (Ran et al., 2013, Jinek 
et al., 2012, Carlson et al., 2012). Studies have shown that targeted mutagenesis using Cas9 
nucleases induce double stranded breaks in an organism’s DNA, complementary to the set of guide 
RNAs encoding for a given gene of interest, and exploit endogenous cellular repair mechanisms 
such as nonhomologous end-joining or homology-directed repair pathways to produce site-specific 
knockout at specific genetic loci with minimal toxicity (Katigbak et al., 2018, Cong et al., 2013, 
Ran et al., 2013, Thurtle-Schmidt & Lo, 2017). Though various strategies exist to increase the 
specificity of genome editing strategies such as zinc-finger nucleases (ZFN) and transcription 
activator-like effector nucleases (TALENs) in embryonic cell lines, CRISPR-Cas9 emerges as a 
reliable mechanism of eukaryotic homologous recombination and genome-scale KO of 
mammalian cell lines (Shalem et al., 2014, San Filippo et al., 2008, Bozas et al., 2009, Chu et al., 
2015). As evident in any field, the cooperation of multiple organizations and individuals with 
different skill sets is necessary for robust outcomes. Recently, the development of techniques and 
appropriate culture conditions to introduce genetic manipulations to study human genetic diseases 
in animal models have expanded the arsenal of researchers and neuroscientists to exploit (Sukoyan 
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et al., 2002). The formation of in vivo germ-line competent chimeras containing the genetic 
knockout of 3-hydroxy-3-methylglutaryl-CoA lyase (HMGCL) against a triple transgenic 
background predisposed to AD pathology and implantation into surrogate mothers was able to 
produce chimeric offspring (Yamamoto et al., 2013) and relevant behavioral test were conducted.  
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Intermittent Metabolic Switching 
Under normal physiological conditions, an organism will absorb the nutrients from a given food 
source and will store excess energy in the form of glycogen primarily in the liver and skeletal 
muscles to maintain healthy blood-glucose levels and supply the tissue with energy in the absence 
of oxygen (Berg et al., 2002). As an organism begins to burn off the stored energy with activity 
and liver glucose reserves are used up, the brain and body will recognize low circulating glucose 
levels and switch the primary energy source of the cells to ketone bodies produced from fatty acids 
released by adipose tissue (Mattson et al., 2018, Courchesne-Loyer et al., 2017, Camandola & 
Mattson, 2017). The “G-K” switch from glucose to ketone body use as the major energy source of 
the cells and subsequent switch back to glucose after food consumption “K-G” has been shown to 
greatly improve the phenotypic presentations of various inflammatory pathways, resistance to 
neuronal injury and oxidative stress, shown to improve lifespans and age-dependent cognitive 
deficits seen in both human and rodent models (Anson et al., 2003, Hatori et al., 2012, Ingram et 
al., 1987, Means et al., 1993). As such, the role of metabolic disturbances in disease progression 
and lifestyle intervention strategies have seen increasing salience. A recent review article by 
Mattson et al. suggests that switching between time-periods of negative energy balance (short 
fasts/exercise) and positive energy balance (eating and resting) can optimize brain health, improve 
mood, and create the conditions for cellular stress resistance and cell growth/neuroplasticity 
pathways in ameliorating neurodegenerative diseases (Longo & Mattson, 2014). Intermittent 
metabolic switching can be defined as scenarios in which an individual’s eating and exercise 
patterns result in periodic changes in glucose or ketone use as the primary energy source and has 
been implicated in providing a range of therapeutic effects including increasing spine density and 
LTP capabilities, reduce seizure induced hippocampal neurodegeneration, and even enhance basal 
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neurogenesis and neuronal survival (Eckles-Smith et al., 2000, Bruce-Keller et al., 1999, Lee et 
al., 2002). The physiological effects of time-restricted feeding (TRF) and alternate-day fasting 
(ADF) methods of experimentally inducing IMS in rodent models have been well characterized in 
reducing aging-related behavioral deficits seen in 3xTg mice models of AD (Halagappa et al., 
2007, Higami et al., 2006, Huber et al., 2017). Similarly, fasting and exercise have been shown to 
upregulate both BDNF and CREB pathways implicated in cellular repair pathways, long-term 
memory, insulin-like growth factor (IGF1) signaling and play key roles in mitochondrial 
biogenesis and LTP (Hirano et al., 2013, Estrada et al., 2009, Llorens-Martin et al., 2009, Hepple 
2009, Marosi et al., 2014). Though the benefits of IMS and caloric restriction/exercise on overall 
brain health and disease pathology have been briefly mentioned role of 3-hydroxy-3-
methylglutaryl-CoA lyase knockout in AD progression has not been previously examined. 
Essentially, training regimens of IMS and periods of fasting/exercise followed by periods of 
eating/resting can improve the metabolic efficiency and stress tolerance of mitochondria through 
SIRT3 pathways, regulate protein synthesis through mechanistic target of rapamycin (mTOR) and 
autophagy pathways, and stimulate the release of peripheral signals that mediate neuroplasticity 
and behavior (Mattson et al., 2018, Cheng et al., 2016, Palacios et al., 2009, Tang et al., 2002, 
Alirezaei et al., 2010, Johnson et al., 2013, Kim et al., 2015). 
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3-Hydroxy-3-Methylglutaryl-CoA Lyase (HMGCL) 
The HMGCL gene encodes for a protein that belongs to the HMG-CoA lyase family necessary for 
ketogenesis and the use of ketone bodies as an alternative energy source by an organisms’ cells 
during periods of low blood glucose or fasting. This protein is a mitochondrial enzyme that 
catalyzes the final step of leucine degradation in ketone body metabolism and is found on 
chromosome 1 of the human genome and chromosome four of the mice genome (The Knockout 
Mouse Project). Genetic knockouts at this target loci may produce challenges to cell viability 
because of the critical nature of ketone body synthesis and energy expenditure demands of 
mitochondrion during periods of fasting, and cell death signatures may be experienced prematurely 
by already susceptible hippocampal neurons of the 3xTg mice. Of note, the few HMGCL 
mutations that have been investigated in human patients have led to severe metabolic acidosis, 
acute metabolic degeneration, and the relevant isoforms of HMGCL transcripts and nature of 
mutations lead to potentially lethal outcomes (Grunert et al., 2017, Fu et al., 2010, Mattson et al., 
2018). As such CRISPR-Cas9 mediate genetic knockout of HMGCL in mice models may result in 
embryonic lethality and gene expression alterations using RNA guided CRISPR-Cas9 systems 
may help potentiate the complex role of ketone body synthesis and use during periods of fasting 
(Wang et al., 1998). Regardless of the efficacy of the specific genetic knockout, the use of genome 
editing strategies to produce high fidelity mutations at specific loci is significant in order to 
elucidate the interaction of specific genotypes with disease and behavioral phenotypes. 
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CRISPR/Cas9-mediated 3xTg/HMGCL-/- Chimera Mouse Line from ES Cell 
All CRISPR transfection protocol of embryonic cell lines and chimeric mouse generation produced 
by Synthego (powered.synthego.com, 2018). Single stem cells are extracted from 3xTg mice 
background and electroporation/nucleofection of cell lines with Cas9 and specifically designed 
sgRNAs to the HMGCL gene on chromosome four (Catrionia 2013, Fig 1). Multiple sgRNA 
transcripts that bind to multiple regions of the HMGCL gene adjacent to a NGG PAM sequence 
included in viral transfection to induce DSB at more specific target sites: 5’ 
CCTGACTCCAAACATGAAAA GG 3’, 5’ TCCTGACTCCAAACATGAAA GG 3’, 5’ 
GACCACTCTGACGTCTTGAA GG 3’. Cell are selectively cultured for those expressed 
mutant germ line DNA and ES cell aggregates are analyzed with qPCR using sequence specific 
oligonucleotides to HMGCL labeled with fluorescent EGFP reporter only after hybridization 
with its complementary strand (TagMan probes). The real-time PCR analysis of whole brain 
tissue of 3xTg/WT ad libitum and 3xTg/HMGCL-/- ad libitum will be conducted and critical 
threshold scores are determined. Colocalization of NeuN and HMGCL-EGFP antibody staining 
was noted in 3xTg/HMGCL-/- ad libitum relative to NonTg/WT ad libitum. Mouse monoclonal 
antibodies received (Chemicon, Catalog number: MAB377) and IHC-Tek antibody diluent 
(Cat#IW-1000) used to reduce unspecific staining. Antigen retrieval used  IHC-TekTM Epitope 
Retrieval Steamer Set (Cat# IW-1102) at 95/100 ºC/room temperature for 20 minutes each. LSAB 
method for detection was utilized and nuclei staining was observed.  
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Figure 1. Generalized workflow of gene KO at one-cell embryonic stage to produce non-mosaic 
gene knockout in all cells followed by surrogate implantation. 
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Animals 
3xTg mice were ordered from The Jackson Lab; available through the JAX MMRRC Stock# 
034830. All mice are housed 5 per cage and kept on 12h light/dark cycles with accessible water 
and minimal animal handling. All euthanization techniques and mice testing/handling meet 
standards approved by the Institutional Animal Care and Use Committee (IACUC). Intermittent 
metabolic switching will be experimentally induced in specific cohorts of 3xTg mice using 24-
hour periods of restricted feeding with a 40% reduction in caloric intake to determine if the 
previously established therapeutic effect of IMS is attenuated in mice with differing genetic 
backgrounds HMGCL KO. Time restricted feeding protocols followed previously established 
methods and food was deprived every other 24 hours (Halagappa et al., 2007, Anson et al., 2003). 
At three months of age, 5 groups of five mice each were assigned to the following dietary regimen: 
non-Tg/WT ad libitum, 3xTg/WT ad libitum, 3xTg/WT TRF + CR, 3xTg/HMGCL-/- ad libitum, 
and 3xTg/HMGCL-/- TRF + CR. Mice on the CR diet were provided an amount that is 60% of the 
amount consumed by the 3xTg/WT ad libitum group. At about 6 months of age, the mice were 
subjected to a hippocampal-dependent spatial memory test to better characterize functional 
differences in gene knockout and therapeutic efficacy of IMS. CSF fluids were drawn at 6 months 
of age and animals were euthanized for whole brain and hippocampal dissection and frozen for 
Aβ1-42, p-tau level analysis and Fluoro-Jade B immunostaining. 
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Morris Water Maze 
Previous studies have shown that both intermittent fasting regimens and caloric restriction 
contribute to improved cognitive ability and ultimately reduce risk of Aβ deposition and tau 
pathology seen in mouse models of Alzheimer pathology (Halagappa et al., 2007, Mattson et al., 
2015, Patel et al., 2005). The behavioral testing followed previously established protocol. A 
circular tank (diameter 1.0 m, height 0.40 m, painted white) was filled with water (22 ± 1°C) and 
water made opaque using non-fat milk. Water will be changed after all mice of a given cohort are 
tested to prevent detritus buildup. Spatial cues are not provided along the ridge of the tub and mice 
given one test run to determine escape latency (s). If mice are unable to find the platform hidden 
1 cm below the surface of the water before the maximum 2-minute mark, mice were manually 
guide to the platform and allowed to acclimate for 1 minute. On day 1 of acquisition trials, mice 
from a given cohort are tested one after another for four cycles as to allow mice to relax between 
trials and prevent over-handling. Escape latency or the time it takes each mouse to reach the 
submerged platform was recorded using a stopwatch. A 24-hour delay was administered after day 
1 of behavioral testing and subsequent preservation or loss of spatial memory is examined. 
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ELISA Immunosorbent Assay of Aβ1-42 and p-Tau Levels 
Enzyme linked immunosorbent assay (ELISA) kits acquired from ThermoFisher.com for mouse 
Aβ1-42 (Catalog number: KMB3441) and phosphorylated tau (p-Tau199, Catalog Number: 
KMB7041) level measurements from cerebrospinal fluid (CSF) of 6-month old mice. In an ELISA, 
an antigen is immobilized to a solid plate and is complexed with an antibody for a given enzyme. 
Elevated insoluble Aβ1-42 levels and phosphorylated tau are well characterized biomarkers of AD 
pathology and subsequent shifts in relative concentrations to the NonTg/WT control were 
measured (Huber et al., 2017, thermofisher.com). Efficient collection of CSF from cisterna magna 
of 6-month old mice followed protocol previously outlined using special stereotaxic guides to hold 
the syringe in place to prevent CSF contamination by blood and other fluids (Zarghami et al., 2013, 
Rosen et al., 2013).  This study could have benefited greatly from repeated measures of minimally-
invasive CSF extractions throughout IMS training initiation at 3-months to see how aging and 
cytotoxic biomarkers contribute to cognitive decline.  
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Hippocampal Dissection 
Hippocampal cell tissue extraction follows standard protocol from previously published studies 
(Mathis et al., 2011). The ACSF components 124 NaCl, 2KCl, 1.25 KH2PO4, 2MgSo4, 26 
NaHCO3, 10 dextrose (in mM)) were combined with distilled H20 were oxygenated vigorously in 
a 2L Erlenmeyer flask. Oxygenated Ca2+-free ACSF poured into separate Erlenmeyer flask and 
transferred to ultrafreezer (-80 °C) for 30 minutes to be used during dissection. To produce the 
media used for brain slice storage after dissection, 2 mM of CaCl2 was added to remaining 1.25 L 
volume of ACSF and oxygenation resumed with 95%O2//5%CO2. Extracted brain tissue 
submerged in Ca2+-free ACSF covered with parafilm and prepared for brain slicing from 
Vibratome sectioning (Leica VT1000 S). Cerebellum and rostral tips of frontal lobe carefully 
dissected out and brain tissue transferred to the sectioning stage of Vibratome filled with ice-cold 
Ca2+-free ACSF. Slices collected with wide-mouth paint brush and transferred to small petri dish 
containing ice-cold Ca2+-free ACSF. Brain slices transferred to holding chamber to bathe in 
oxygenated Ca2+-containing ACSF and chamber temperature increase +1°C every five minutes 
to 32°C.  
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Cellular Degeneration Identification using Fluoro-Jade B 
Fluoro-Jade B has shown to exhibit greater target specificity of neurons undergoing degeneration 
with minimal background staining than earlier Fluoro-Jade staining methods (Schmued & 
Hopkins, 2000). Fluoro-Jade B positive neuron measurements in this study follow standard 
procedures from previously cited literature (Laflamme et al., 2016). Tissue sections mounted on 
Superfrost plus slide (Thermo Fisher Scientific, catalog number: 12-550-17 ) and fixed for 20 min 
in paraformaldehyde 4%, and 2 minutes in KPBS (Electron Microscopy Science, catalog 
number: 19210 ) Dehydrated with 50%-70%-100% Ethanol for 2 minutes each and rehydrated 
with 70%-50% Ethanol and KPBS. Incubated in potassium permanganate 0.06% for 5 min at room 
temperature, rinsed in water, and incubated in Fluoro-Jade B solution on orbital shaker (Merck 
Millipore Corporation, catalog number: AG310 ). Slides kept covered from light and dried under 
vacuum at room temperature after three rinses with water. Slide cleared with Xylene three times 
at 2 minutes each and slip covered with DPX before drying under hood (Sigma-Aldrich, catalog 
number:534056, Electron Microscopy Science, catalog number: 13512). Immunofluorescent of 
Fluoro-Jade positive hippocampal cells counted using EVOS FL Auto Imaging System (SKU# 
AMAFD1000). 
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Confirmation of Gene Knockout  
Relative fluorescence of qPCR antibodies for anti-HMGCL loci in 3xTg/HMGCL-/- and 
NonTg/WT hippocampal cell homogenates reveal reduced critical threshold value from 
NonTg/WT samples. Significant quantities of HMGCL loci binding in NonTg/WT is apparent 
nearly twice as quickly than in 3xTg/HMGCL-/- mice samples (Fig 2). Colocalization of NeuN 
and HMGCL/EGFP staining reveal HMGCL preservation in physiologically relevant neurons 
of the hippocampus but the lack of EGFP-staining suggests genetic knockout compared to the 
wild-type (Fig 3).  
 
Figure 2. Diminished critical threshold score from quantitative PCR of 3xTg/WT mice compared 
to 3xTg/HMGCL-/- mice (n=1). 
 
Figure 3. Characterization of NeuN and HMGCL-EGFP in a) 3xTg/HMGCL-/- and b) 
NonTg/WT 
  
 20 
Increased Hippocampal-Dependent Spatial Memory Deficits seen in 3xTg HMGCL-/- mice 
Mean escape latency measurements trends suggest similar cognitive phenotypes of NonTg/WT 
and 3xTg/WT mice on the TRF + CR regimen (Fig. 4). The phenotypic presentation of 3xTg/WT 
ad libitum mice in spatial memory behavioral tests have been well characterized in recent 
Alzheimer disease mice models, demonstrate delayed learning speed and altered retention of 
spatial memory, and serves as the control to compare behavioral data (Huber et al., 2017, 
Sterniczuk et al., 2010, Gimenez-Llort et al., 2013, Clinton et al, 2007). Latency reduction of 3xTg 
and memory preservation is evident between 3xTg/WT ad libitum and 3xTg/WT TRF+CR cohorts 
as evidenced by consistent latency times following the 24-hour break in the IMS induced mice. 
Interestingly, the escape latencies of both HMGCL KO mice regardless of training regimen 
experience marked differences in mean latency scores and the IMS training regimen was not 
sufficient to improve cognitive deficit attenuation seen in 3xTg/WT TRF+CR compared to 
3xTg/WT ad libitum trials. The 3xTg/HMGCL-/- mice exhibit significantly longer escape latency 
times with the mice swimming close to the maximum allotted swim time with each trial, and 
significant latency reductions were not observed between trials such as in the 3xTg/WT TRF+CR 
mice (Fig 4.) All groups see a similar upward trend toward the end of their acquisition trials likely 
due to over-handling. 
 
  
 21 
 
 
Figure 4. Summary of mean escape latency of hippocampal-dependent MWM cognitive tests 
(n=5). NonTg/WT = dashed square; 3xTg/WT TRF + CR = blue circle; 3xTg/WT ad libitum = 
blue triangle; 3xTg/HMGCL-/- TRF + CR = grey diamond; 3xTg/HMGCL-/- ad libitum = grey 
square 
 
 
 
 
 
 
 
 
 
 
 
 
24 HOUR 
DELAY 
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Elevated Aβ1-42 and p-Tau199 from CSF 
ELISA Immunosorbent Assay analysis of insoluble Aβ1-42 from the five cohorts reveal 
significantly elevated concentrations in 3xTg/WT ad libitum compared to NonTg/WT and 
3xTg/WT TRF + CR (Fig 5). Interestingly, though 3xTg/WT TRF+CR show slightly elevated 
concentrations of Aβ1-42 protein, statistical significance is not determined. Mice in the 
3xTg/HMGCL-/- TRF + CR cohort show ~35% increase in Aβ concentration compared to 
3xTg/WT mice experiencing the same IMS regimen whereas 3xTg/HMGCL -/- ad libitum 
experience a 250% increase in Aβ accumulation. Analysis of phosphorylation of tau protein at 
Ser199 of the wild-type and chimeric mice reveal similar concentrations between NonTg/WT ad 
libitum and 3xTg/WT TRF+CR. A nearly 50% increase in p-tau concentration is noticed in 
3xTg/WT ad libitum mice relative to controls for transgene and IMS regimen. Both 
3xTg/HMGCL-/- exhibit nearly 200% increases in phosphorylated tau concentrations and 
correlate with the worst phenotypic presentations in Morris Water Maze. 
 
 
Figure 5. Relative Aβ1-42 and p-tau levels normalized to NonTg/WT mice and significant 
associations between HMGCL KO and experimental conditions are identified (n=5). 
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Fluoro-Jade B Positive Staining of Hippocampal Slices 
Hippocampal neurons exhibiting positive Fluoro-Jade B staining were elevated to noticeable levels 
in 3xTg KO mice and IMS training regimen was insufficient to ameliorate cell degeneration 
processes (Fig 6.) The 3xTg/WT ad libitum mice experience one order of magnitude larger in cell 
death markers relative to 3xTg/WT TRF+CR and NonTg/WT cohorts. However, insignificant 
differences were determined between 3xTg/WT ad libitum and 3xTg/HMGCL-/- TRF+CR mice. 
The elevated counts of Fluoro-Jade B positive hippocampal neurons in 3xTg/HMGCL-/- ad 
libitum mice were expected but a significant difference existed with the 3xTg/HMGCL-/- 
TRF+CR.  
 
 
Figure 6. Fluoro-Jade B fluorescent neurons in the hippocampus seen noticeably in HMGCL KO 
mice and IMS regimen could not recover memory deficits or attenuate Aβ and p-tau levels (n=5). 
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Discussion 
An increasingly sedentary and overindulgent lifestyle of modern Western societies have shown 
to contribute to complex pathologies of various metabolic and neurodegenerative conditions. 
The therapeutic potential of IMS and everyday lifestyle management shifts have been attributed 
to a variety of neuroprotective, synaptic plasticity, and attenuating cognitive decline in both 
human and AD animal models. Current research continues to elucidate the role of diet and 
exercise in decelerating disease progression and providing neuroprotective pathways against 
pathogenesis. This paper has addressed the three specific hypotheses originally posited by 
successful genetic and visual confirmation of targeted knockout of chimeric mouse strains 
predisposed for AD pathology, demonstration of the hippocampal-dependent spatial memory 
deficit mitigation of intermittent metabolic switching regimens to 3xTg mice, and analysis of 
the classical hallmarks of Aβ1-42, p-tau and cell degeneration biomarkers. As expected, 
NonTg/WT and 3xTg/WT TRF+CR mice exhibited similar cognitive abilities in MWM and 
relative concentrations of the enzymes and proteins associated with AD pathology leading to 
cellular death (Fig 4). IMS has been shown to enhance cell-stress resistance and neuroplasticity, 
the relatively low levels of Fluoro-Jade B staining of 3xTg/WT TRF+CR a make sense as more 
neurons are resilient to the degrading nature of Aβ oligomers and phosphorylated tau. Initially, 
it was expected that mice receiving TRF+CR training regimen would experience overall 
improvements in behavioral abilities and phenotypic presentations but the 3xTg/HMGCL-/- 
TRF+CR performed relatively poorly in all aspects. Interestingly, in both HMGCL KO cohorts, 
marked elevations in Aβ1-42 and p-tau proteins were recognized. The necessary role of HMGCL 
protein in proper mitochondrial function during the fasting period and subsequent gene editing of 
this loci may contribute to the increase in cell death markers seen in HMGCL KO cohorts relative 
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to 3xTg/WT mice. Mice following the IMS diet in the 3xTg/HMGCL-/- group showed decreased 
relative Aβ1-42, pTau, and Fluoro-Jade B positive staining relative to ad libitum groups. The 
ability of TRF+CR to prepare neuronal populations for stressful environments and subsequent 
neuronal degeneration from aberrant amyloid and tau pathologies is evidenced by the decreased 
Fluoro-Jade staining seen in 3xTg/HMGCL-/- TRF + CR compared to 3xTg/HMGCL-/- ad 
libitum. The creation of chimeric mouse strains encoding for HMGCL enzyme knockout against 
a genetic background predisposed for AD progression highlights the complex interaction of the 
gene and environment on phenotypic presentations of a disease and a patient’s response to a given 
therapeutic. The application of high fidelity genome editing and growing understanding of 
embryonic cell lines and genomic analysis continue to improve the arsenal of researchers to 
reliably translate genomic data into personalized treatments. Manipulating CRISPR/Cas9 systems 
for targeted gene expression modifications instead of permanent genetic knockout is emerging at 
the forefront of gene therapies and mouse models of disease pathologies. With a growing 
understanding of functional genomics and endogenous gene expression modifications, researchers 
may refine the CRISPR/Cas9 systems to non-invasively, non-permanently alter protein expression 
and functional/phenotypic presentations can be measured. Differing training regimens such as 
longer food restriction periods or exercise-coupled IMS may contribute to different degrees of 
cognitive attenuation and the exact nature of IMS regimens could be further developed. Ultimately, 
an individual’s genetic makeup may determine the propensity for aberrant signaling and cellular 
dysfunction but environmental cues and lifestyle characteristics play a huge role in the pathologies 
of neurodegenerative diseases. Currently, randomized, double blind clinical trials prescribing 
individualized training regimens for older patients at risk for developing dementia-like disorders 
is underway and clinical applications of daily lifestyle management may be seen as early as 2018. 
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